Hydrinity’s R&D journey: From advanced wound care to microfusion technology



Hydrinity s R D journey From advanced wound care to microfusion technology

In the fast-paced world of skincare, innovation is key to staying ahead, and skin care brand Hydrinity has focused on innovating the space by blending advanced science with a focus on inclusive luxury. Under the leadership of CEO Keith O’Briant, the company is making strides with its patented Hyaluronic Acid and PPM6 Technology, aiming to address a diverse range of skin types with a commitment to simplicity and efficacy.

In this CosmeticsDesign Q&A, O’Briant provides insights into Hydrinity’s rigorous R&D process, detailing the steps from initial concept to final product, and how the company integrates cutting-edge technology and sustainable practices into their skin care product formulation development efforts.

CDU: Can you describe the R&D process at Hydrinity? What steps do you take from initial concept to final product?

Keith O’Briant (KOB)​: At Hydrinity, our R&D process is quite the journey, and we pride ourselves on being meticulous at every stage. It all starts with identifying a need or a gap in the skin care market, often inspired by customer feedback or emerging scientific research. From there, our team brainstorms and conceptualizes potential solutions, which then leads to the formulation stage.

We experiment with various ingredients and technologies, testing countless formulations in our lab. Once we have a promising prototype, we conduct rigorous clinical trials to ensure efficacy and safety. This involves everything from lab tests to real-world usage by volunteers. Only after a product passes these stringent tests with flying colors do we move on to final production and packaging. It’s a long road, but seeing the positive impact on our customers’ skin makes it all worth it.



Source link

About The Author

Scroll to Top